MICHAEL DIEFENBACH, the Feinstein Institute for Medical Research scientist and Northwell Health director of Behavioral Research in the Department of Medicine and Urology, demonstrated an app to help with decision-making for prostate cancer treatment. Prostate cancer patients face a variety of treatment options ranging from immediate surgery and/or radiation to health care professionals observing the...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
